Immunotherapy in the neoadjuvant setting shows promise for patients with stage III lung cancer.
Ashish Saxena, MD, PhD
Advertisement
Articles by Ashish Saxena, MD, PhD
Advertisement
Latest Updated Articles
Expanding Treatment in The Neoadjuvant SettingNovember 19th 2019
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses
2
Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses
3
Addressing Financial Toxicity: Team-Based Workflows in Oncology Care
4
Early Amivantamab Experience and Subcutaneous Dosing in COPERNICUS
5